Alkylating Drug class drugs

9 results

  • bendeka

    (bendamustine hydrochloride)
    Teva Pharmaceuticals USA, Inc.
    BENDEKA® is indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of rituximab treatment. Efficacy compared to first-line therapies other than chlorambucil is not established.
    Medication Details
    Drug Interactions

  • busulfan

    (Busulfan)
    Mylan Institutional LLC
    Busulfan injection is indicated as part of a conditioning regimen with cyclophosphamide before allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
    Medication Details
    Drug Interactions

  • busulfex

    (busulfan)
    Otsuka America Pharmaceutical, Inc.
    BUSULFEX is indicated for use alongside cyclophosphamide as a conditioning regimen before allogeneic hematopoietic progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Medication Details
    Drug Interactions

  • carmustine

    (carmustine)
    Zydus Pharmaceuticals USA Inc.
    Carmustine for injection is indicated for palliative therapy in brain tumors (glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, metastatic brain tumors), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (in combination with other approved drugs).
    Medication Details

  • gliadel

    (carmustine)
    Arbor Pharmaceuticals
    GLIADEL Wafer is indicated for treating newly-diagnosed high-grade glioma as an adjunct to surgery and radiation, and for recurrent glioblastoma as an adjunct to surgery.
    Medication Details
    Drug Interactions

  • jelmyto

    (mitomycin)
    UroGen Pharma, Inc.
    JELMYTO® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).
    Medication Details

  • melphalan hydrochloride

    (Melphalan Hydrochloride)
    BPI Labs LLC
    Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma when oral therapy is not suitable.
    Medication Details

  • valchlor

    (mechlorethamine hydrochloride)
    Helsinn Therapeutics (U.S.), Inc.
    VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have previously undergone skin-directed therapy.
    Medication Details
    Drug Interactions

  • yondelis

    (Trabectedin)
    Janssen Products, LP
    YONDELIS® is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received an anthracycline-containing regimen.
    Medication Details
    Drug Interactions